USPTO serial 79460406
MARIGOLD THERAPEUTICS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- —
- Law office
- —
What this means
Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.
Need help with MARIGOLD THERAPEUTICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medicines for human purposes; pharmaceutical preparations for suppressing tumors; immunostimulants; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations and substances for the treatment of metabolic diseases and disorders. | ACTIVE | — |
| 035 | Provision of an online marketplace for buyers and sellers of goods and services; procurement services for others [purchasing goods and services for other businesses]; sales promotion for others; retail services for pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale services for pharmaceutical, veterinary and sanitary preparations and medical supplies; retail or wholesale services for medicines; retail or wholesale services for pharmaceutical preparations. | ACTIVE | — |
| 042 | Technological research; conducting technical project studies; research and development of new products for others; research and development services in the field of antibodies; research and development of pharmaceutical preparations for treating malignant tumours; research and development services in the field of immunology; clinical trials; medical research; culturing of cells for scientific research purposes; scientific research in the field of genetics. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 5, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 20, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 20, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 15, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |